0001824618-20-000001.txt : 20200924
0001824618-20-000001.hdr.sgml : 20200924
20200924094153
ACCESSION NUMBER: 0001824618-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200924
DATE AS OF CHANGE: 20200924
EFFECTIVENESS DATE: 20200924
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cedilla Therapeutics, Inc.
CENTRAL INDEX KEY: 0001824618
IRS NUMBER: 822647784
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-376252
FILM NUMBER: 201193739
BUSINESS ADDRESS:
STREET 1: 38 SIDNEY STREET, FLOOR 2
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617- 281-5658
MAIL ADDRESS:
STREET 1: 38 SIDNEY STREET, FLOOR 2
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
D
1
primary_doc.xml
X0708
D
LIVE
0001824618
Cedilla Therapeutics, Inc.
38 SIDNEY STREET, FLOOR 2
CAMBRIDGE
MA
MASSACHUSETTS
02139
617- 281-5658
DELAWARE
None
None
Corporation
true
2017
Alexandra
Glucksmann
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
Eli
Casdin
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Director
Dominik
Naczynski
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Director
Abbie
Celniker
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Director
Neil
Exter
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Director
Rosana
Kapeller
38 Sidney Street
Floor 2
Cambridge
MA
MASSACHUSETTS
02139
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-09-09
true
true
false
0
60000000
30359999
29640001
false
16
0
0
0
false
Cedilla Therapeutics, Inc.
/s/ Alexandra Glucksmann
Alexandra Glucksmann
President and Chief Executive Officer
2020-09-24